Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | M7437 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on M7437, a putative antibody-drug conjugate (ADC) targeting lymphocyte antigen 6 complex locus E (Ly6E) (Jan 2026). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| M7437 | Limited information is currently available on M7437, a putative antibody-drug conjugate (ADC) targeting lymphocyte antigen 6 complex locus E (Ly6E) (Jan 2026). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07311603 | Phase I | M7437 | Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors | Not yet recruiting | DEU | 0 |
| NCT07360314 | Phase I | M7437 | Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors | Not yet recruiting | USA | ESP | CAN | 1 |